Godavari Drugs Ltd Share Price Today - Live Chart & Stock Info | PL Capital

Godavari Drugs Ltd

Godavari Drugs
Small Cap | Pharmaceuticals
₹ 88.51 -2.18(-2.4%)
Last updated: 05-Feb-2026 , 16:01:53

Godavari Drugs Ltd Live Price Chart

Low: ₹88 High: 96.96
Open Your Demat Account
with PL Capital now
10 Lakh+ Active users
Award Winning research insights
No hidden charges

Godavari Drugs Ltd Technicals

Current Price
₹ 88.51 -2.18 (-2.4%)
EMASMA
20 Day ₹ 88.411
50 Day ₹ 85.152
100 Day ₹ 84.500
200 Day ₹ 87.248
20 Day ₹ 89.946
50 Day ₹ 81.920
100 Day ₹ 82.735
200 Day ₹ 86.611

Godavari Drugs Ltd Performance

Previous Close ₹ 90.69
High ₹ 96.96
Volume 4196
52W Range ₹ 69.7 - ₹ 115
Open ₹ 96.96
Low ₹ 88
Market Cap ₹ 57 Cr

Godavari Drugs Ltd Fundamentals

ROCE 7.472
P/E Ratio 15.580
P/B Ratio 1.580
Industry P/E 1.580
Debt to Equity 39.828
ROE 8.156
EPS 5.820
Dividend Yield 0.000
Book Value 57.561
Face Value 10.000

Godavari Drugs Ltd Financials

Particulars Y202503 Y202403 Y202303 Y202203 Y202103
Total Revenue 114.3273 157.3294 160.2801 161.3825 123.0803
Total Expenses 108.7019 150.3172 155.5749 154.3619 117.3739
Profit After Tax 4.38 5.5489 3.7858 5.2453 4.1281

Godavari Drugs Ltd Shareholding Pattern

Promoter Holdings 52.609 %
FIIs 0.000 %
DIIs 0.498 %
MutualFund 0.000 %
Retail 36.879 %
Others - 10.014 %

About Godavari Drugs Ltd

History of Godavari Drugs Ltd

Godavari Drugs Limited is engaged in the business of manufacture of Active Pharmaceutical Ingredients (API) and drug intermediates, through its manufacturing facility at Nanded, Maharashtra, India.. Sulphamethoxazole (SMX), the main product of the company, is a widely used anti-bacterial drug enjoying good export demand. The Company incorporated in December, 1987, has multiple production blocks for API's, drug intermediates and fine chemicals. The company has expanded its SMX capacity from 540 tpa to 720 tpa, integrating backward into the manufacture of drug intermediates, sulphamethoxide (cap.: 450 tpa) and diethyl oxalate, DEO (cap.: 750 tpa), and diversifying into the manufacture of trimetroprim, TMP (cap.: 144 tpa). The diversification into TMP is beneficial as SMX and TMP are used in combination to treat a wide variety of infections. The backward integration into SMO and DEO will enhance value-addition. In fact, Siris and Chemox Chemicals, both having good capacities of SMX, have recently gone in for the production of SMO. In 2000 the company introduced 'Pyrazyamide' in the market. Since the product is being well accepted in the market the company is planning to increase the capacity of 'Pyrazyamide' of 180 TPA and have also finalised on other products Cislactum,which is a intermediate used to produce Diltiazem an anti anginal drug. The Company combine their intrinsic strengths in chemistry with capabilities of process development, right from laboratory ...

FAQs on Godavari Drugs Ltd

1. Can I buy Godavari Drugs Ltd from PL Capital?

Yes, you can invest in Godavari Drugs Ltd shares directly through PL Capital. Our platform provides a seamless and secure way to buy, hold, and track Godavari Drugs Ltd stock along with other leading companies listed on the NSE and BSE. Simply open a Demat and trading account with PL Capital, and you’ll be able to trade Godavari Drugs Ltd as well as diversify your portfolio across equities, mutual funds, IPOs, and more.

2. Does Godavari Drugs Ltd pay dividends?

Godavari Drugs Ltd does not currently pay dividends. Investors in this case primarily benefit from capital appreciation, where the value of the stock may rise over time depending on business growth and market conditions.

3. What is the current share price of Godavari Drugs Ltd ?

As of 05-Feb-2026 , 16:01:53 the share price for Godavari Drugs Ltd. is ₹ 88.51 on the NSE (Note: Prices are dynamic and update frequently during market hours).

4. What is the 52-week high and low of Godavari Drugs Ltd ?

The 52-week high and low of Godavari Drugs Ltd share price is ₹ 69.7 - ₹ 115 as of 05-Feb-2026 , 16:01:53 .
App QR Code

Download the PL Capital App

Open Demat Account
×